首页> 外文期刊>American Journal of Physiology >Axial heterogeneity of vasopressin-receptor subtypes along the human and mouse collecting duct.
【24h】

Axial heterogeneity of vasopressin-receptor subtypes along the human and mouse collecting duct.

机译:血管加压素受体亚型沿人和小鼠收集管的轴向异质性。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Vasopressin and vasopressin antagonists are finding expanded use in mouse models of disease and in clinical medicine. To provide further insight into the physiological role of V1a and V2 vasopressin receptors in the human and mouse kidney, intrarenal localization of the receptors mRNA was determined by in situ hybridization. V2-receptor mRNA was predominantly expressed in the medulla, whereas mRNA for V1a receptors predominated in the cortex. The segmental localization of vasopressin-receptor mRNAs was determined using simultaneous in situ hybridization and immunohistochemistry for segment-specific markers, including aquaporin-2, Dolichos biflorus agglutinin, epithelial Na channels, Tamm Horsfall glycoprotein, and thiazide-sensitive Na(+)-Cl(-) cotransporter. Notably, V1a receptor expression was exclusively expressed in V-ATPase/anion exchanger-1-labeled alpha-intercalated cells of the medullary collecting duct in both mouse and human kidney. In cortical collecting ducts, V1a mRNA was more widespread and detected in both principal and intercalated cells. V2-receptor mRNA is diffusely expressed along the collecting ducts in both mouse and human kidney, with higher expression levels in the medulla. These results demonstrate heterogenous axial expression of both V1a and V2 vasopressin receptors along the human and mouse collecting duct. The restricted expression of V1a-receptor mRNA in intercalated cells suggests a role for this receptor in acid-base balance. These findings further suggest distinct regulation of renal transport function by AVP through V1a and V2 receptors in the cortex vs. the medulla.
机译:血管加压素和加压素拮抗剂正在疾病小鼠模型和临床医学中得到广泛使用。为了进一步了解V1a和V2血管加压素受体在人和小鼠肾脏中的生理作用,通过原位杂交确定了受体mRNA在肾内的定位。 V2受体的mRNA主要在髓质中表达,而V1a受体的mRNA在皮质中占主导。使用同时原位杂交和免疫组化的特定片段标记物,包括aquaporin-2,Dolichos biflorus凝集素,上皮Na通道,Tamm Horsfall糖蛋白和噻嗪类敏感的Na(+)-Cl,使用同时原位杂交和免疫组化方法确定血管加压素受体mRNA的片段定位(-)共同运输者。值得注意的是,V1a受体表达仅在小鼠和人肾脏的髓质收集管的V-ATPase /阴离子交换剂1标记的α插入的细胞中表达。在皮层收集管中,V1a mRNA分布更广泛,在主细胞和插层细胞中均可检测到。 V2-受体mRNA在小鼠和人肾脏中均沿收集管扩散表达,在髓质中具有较高的表达水平。这些结果表明,沿人类和小鼠的集合管,V1a和V2加压素受体的轴向异质表达。插层细胞中V1a-受体mRNA的表达受限制表明该受体在酸碱平衡中的作用。这些发现进一步表明,AVP通过皮层与髓质中的V1a和V2受体对肾脏转运功能的独特调节。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号